Sorry, you need to enable JavaScript to visit this website.

How TECVAYLI® (teclistamab-cqyv) Works

Yellow pointer iconTECVAYLI®, a bispecific antibody, is the first treatment of its kind designed to fight multiple myeloma

Man handing young girl a teacup through her clubhouse window

TECVAYLI® works by helping your immune system locate the multiple myeloma cells in your body.

One side of TECVAYLI® binds to proteins called BCMA, which are found on multiple myeloma cells (as well as some healthy cells). The other side binds to proteins called CD3, which are found on your T-cells.

In doing so, TECVAYLI® is able to activate the T-cells in your immune system to destroy the multiple myeloma cells in the rest of your body.

TECVAYLI® is a kind of medicine called a bispecific antibody, which means it attaches to 2 different cells.

Cartoon t-cell and multiple myeloma cell
May help you fight your disease



Once you and your doctor have decided that TECVAYLI® is right for you, Janssen has resources to help support your treatment journey.

Personalized one-on-one support

Starting and staying on track with a new medication can feel overwhelming. A Janssen Compass® Care Navigator is here to help with free personalized one-on-one support over the phone throughout your treatment journey.

You will talk to the same Care Navigator on every phone call. They will help you in 3 key areas:

  • Explore options that may help you pay for your medication
  • Learn more about your cancer and Janssen medication
  • Find resources for your practical and emotional needs while coping with cancer

Janssen Compass® is limited to education about your Janssen therapy, its administration, and/or your disease. It is intended to supplement your understanding of your therapy and is not intended to provide medical advice, replace a treatment plan from your doctor or nurse, or serve as a reason for you to start or stay on this medication.